Cargando…
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
BACKGROUND: Although almost a year has passed since the Coronavirus disease 2019 (COVID-19) outbreak and promising reports of vaccines have been presented, we still have a long way until these measures are available for all. Furthermore, the most appropriate corticosteroid and dose in the treatment...
Autores principales: | Ranjbar, Keivan, Moghadami, Mohsen, Mirahmadizadeh, Alireza, Fallahi, Mohammad Javad, Khaloo, Vahid, Shahriarirad, Reza, Erfani, Amirhossein, Khodamoradi, Zohre, Gholampoor Saadi, Mohammad Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035859/ https://www.ncbi.nlm.nih.gov/pubmed/33838657 http://dx.doi.org/10.1186/s12879-021-06045-3 |
Ejemplares similares
-
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
por: Ranjbar, Keivan, et al.
Publicado: (2021) -
Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran
por: Shahriarirad, Reza, et al.
Publicado: (2020) -
The mental health impact of COVID-19 outbreak: a Nationwide Survey in Iran
por: Shahriarirad, Reza, et al.
Publicado: (2021) -
Evaluation of students' attitude and emotions towards the sudden closure of schools during the COVID-19 pandemic: a cross-sectional study
por: Mirahmadizadeh, Alireza, et al.
Publicado: (2020) -
Primary malignant epithelioid hemangioendothelioma of the pleura: A review and report of a novel case
por: Rezvani, Alireza, et al.
Publicado: (2022)